Literature DB >> 6119778

Investigations on the penetration of ranitidine into the cerebrospinal fluid and a comparison of the effects of ranitidine and cimetidine on male sex hormones.

R P Walt, S J LaBrooy, A Avgerinos, T Oehr, A Riley, J J Misiewicz.   

Abstract

Cerebrospinal fluid (CSF) ranitidine concentrations were measured in 13 normal subjects undergoing routine myelography following either one, or two doses ranitidine 200 mg. Small amounts of the drug were detectable in the CSF. A separate investigation of duodenal ulcer patients compared the effects of ranitidine 150 mg twice-daily and cimetidine 1 g daily on basal and stimulated levels of male reproductive hormones in the plasma. Although cimetidine treatment resulted in a small rise in basal and stimulated testosterone, neither drug was associated with significant changes in basal or stimulated hormone levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119778

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  17 in total

Review 1.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Plasma concentrations of pituitary and peripheral hormones during ranitidine treatment for two years in men with duodenal ulcer.

Authors:  U Knigge; B Thuesen; A Dejgaard; P Bennett; P M Christiansen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Antiprostatic effect of cimetidine in rats.

Authors:  P Pinelli; S Trivulzio; R Colombo; D Cocchi; R Faravelli; F Caviezel; G Galmozzi; R Cavallaro
Journal:  Agents Actions       Date:  1987-12

Review 5.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

6.  Ranitidine and testosterone secretion in man.

Authors:  V Savarino; M Giusti; C Mansi; M Marugo; G Delitala; G Celle
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

Review 7.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 8.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 9.  Clinical pharmacokinetics of ranitidine.

Authors:  C J Roberts
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

10.  Single blind comparative study of ranitidine and cimetidine in patients with gastric ulcer. The Belgian Peptic Ulcer Study Group.

Authors: 
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.